Citation Tools
Original Articles
A phase II trial of intravenous etoposide (VP-16-213) in epithelial ovarian cancer resistant to cisplatin or carboplatin: clinical and serological evidence of activity
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- A phase II trial of intravenous etoposide (VP-16-213) in epithelial ovarian cancer resistant to cisplatin or carboplatin: clinical and serological evidence of activity